SJL
BMY icon

Shayne & Jacobs LLC’s Bristol-Myers Squibb BMY Stock Holding History

Shayne & Jacobs LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Buy
37,615
+89
+0.2% +$5.11K 0.64% 33
2026
Q1 		$2.28M Buy
37,526
+93
+0.2% +$5.42K 0.7% 30
2025
Q4 		$2.02M Buy
37,433
+109
+0.3% +$5.24K 0.61% 32
2025
Q3 		$1.68M Buy
37,324
+113
+0.3% +$5.28K 0.52% 34
2025
Q2 		$1.72M Sell
37,211
-302
-0.8% -$14.8K 0.57% 34
2025
Q1 		$2.29M Sell
37,513
-258
-0.7% -$15K 0.56% 21
2024
Q4 		$2.14M Sell
37,771
-1,742
-4% -$97.3K 0.56% 24
2024
Q3 		$2.04M Buy
39,513
+96
+0.2% +$4.5K 0.51% 29
2024
Q2 		$1.64M Buy
39,417
+29,573
+300% +$1.32M 0.45% 30
2024
Q1 		$534K Buy
9,844
+91
+0.9% +$4.64K 0.15% 63
2023
Q4 		$500K Sell
9,753
-518
-5% -$27.2K 0.16% 60
2023
Q3 		$596K Buy
10,271
+1,318
+15% +$80.8K 0.2% 54
2023
Q2 		$573K Buy
8,953
+60
+0.7% +$4.02K 0.29% 17
2023
Q1 		$616K Buy
8,893
+1,257
+16% +$88.7K 0.34% 17
2022
Q4 		$549K Buy
7,636
+49
+0.6% +$3.69K 0.3% 17
2022
Q3 		$539K Buy
7,587
+52
+0.7% +$3.77K 0.34% 17
2022
Q2 		$580K Buy
7,535
+51
+0.7% +$3.88K 0.34% 17
2022
Q1 		$547K Buy
7,484
+58
+0.8% +$3.89K 0.27% 20
2021
Q4 		$463K Buy
7,426
+2,908
+64% +$171K 0.25% 24
2021
Q3 		$267K Buy
4,518
+29
+0.6% +$1.91K 0.15% 32
2021
Q2 		$300K Buy
4,489
+30
+0.7% +$1.96K 0.17% 29
2021
Q1 		$281K Buy
4,459
+30
+0.7% +$1.87K 0.17% 32
2020
Q4 		$275K Buy
4,429
+28
+0.6% +$1.72K 0.18% 29
2020
Q3 		$265K Buy
4,401
+30
+0.7% +$1.81K 0.2% 27
2020
Q2 		$257K Buy
4,371
+29
+0.7% +$1.74K 0.22% 25
2020
Q1 		$242K Buy
4,342
+26
+0.6% +$1.59K 0.19% 23
2019
Q4 		$277K Buy
4,316
+28
+0.7% +$1.6K 0.16% 24
2019
Q3 		$217K Buy
+4,288
New +$202K 0.14% 30
2019
Q2 		– Sell
-4,222
Closed -$201K – 30
2019
Q1 		$201K Buy
4,222
+30
+0.7% +$1.49K 0.14% 25
2018
Q4 		$218K Buy
4,192
+29
+0.7% +$1.56K 0.16% 23
2018
Q3 		$258K Buy
4,163
+24
+0.6% +$1.42K 0.17% 21
2018
Q2 		$229K Buy
4,139
+28
+0.7% +$1.51K 0.16% 21
2018
Q1 		$260K Buy
4,111
+22
+0.5% +$1.42K 0.18% 21
2017
Q4 		$251K Buy
4,089
+23
+0.6% +$1.44K 0.17% 23
2017
Q3 		$259K Buy
4,066
+25
+0.6% +$1.46K 0.2% 23
2017
Q2 		$225K Buy
4,041
+24
+0.6% +$1.31K 0.18% 24
2017
Q1 		$218K Buy
4,017
+27
+0.7% +$1.48K 0.17% 23
2016
Q4 		$233K Buy
3,990
+26
+0.7% +$1.42K 0.18% 19
2016
Q3 		$214K Buy
3,964
+18
+0.5% +$1.16K 0.18% 20
2016
Q2 		$290K Buy
3,946
+18
+0.5% +$1.27K 0.24% 16
2016
Q1 		$251K Buy
3,928
+21
+0.5% +$1.32K 0.21% 16
2015
Q4 		$269K Buy
3,907
+19
+0.5% +$1.26K 0.26% 16
2015
Q3 		$230K Buy
3,888
+20
+0.5% +$1.27K 0.2% 16
2015
Q2 		$257K Buy
3,868
+19
+0.5% +$1.25K 0.21% 16
2015
Q1 		$248K Buy
3,849
+20
+0.5% +$1.25K 0.19% 19
2014
Q4 		$226K Buy
+3,829
New +$216K 0.17% 21
2014
Q3 		– Sell
-4,278
Closed -$208K – 22
2014
Q2 		$208K Buy
4,278
+24
+0.6% +$1.18K 0.17% 20
2014
Q1 		$221K Buy
4,254
+23
+0.5% +$1.22K 0.18% 22
2013
Q4 		$225K Buy
+4,231
New +$216K 0.19% 22

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Shayne & Jacobs LLC's BMY Position: Q2 2026 in Review

Shayne & Jacobs LLC increased its Bristol-Myers Squibb (BMY) stake by 0.24% in Q2 2026, buying an estimated $5.11K and bringing the position to 37,615 shares worth $2.17M. The position accounts for 0.64% of the portfolio, ranked #33.

Shayne & Jacobs LLC first reported a position in BMY in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.29M in Q1 2025. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Shayne & Jacobs LLC held 37,615 shares of Bristol-Myers Squibb worth $2.17M as of Q2 2026.
  • Shayne & Jacobs LLC bought 89 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.11K.
  • Bristol-Myers Squibb made up 0.64% of Shayne & Jacobs LLC's portfolio in Q2 2026, its #33 holding.
  • Shayne & Jacobs LLC first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 49 quarters since.
  • Shayne & Jacobs LLC's Bristol-Myers Squibb position peaked at $2.29M in Q1 2025.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Shayne & Jacobs LLC's 13F filing for Q2 2026, filed 7 Jul 2026.